New Rhein Healthcare Investors

Venture Capital and Private Equity PrincipalsPennsylvania, United States11-50 Employees

New Rhein applies a private equity investment approach to life sciences venture capital investing, with a focus on later-stage, de-risked assets with proven clinical safety and efficacy. We believe that product development execution and strategic exits are the most important drivers of investment returns. Our goal is to develop products that deliver important health benefits to patients, compelling economic value to payors, and generate capital gains through strategic exits.
 
We invest broadly across all therapeutic areas. Our team of seasoned executives from leading pharma and MedTech firms bring deep expertise in the evaluation and development of products, including hands-on experience in R&D, CMC, commercialization, and M&A. This drives our sourcing, diligence, and execution, enabling us to scale companies and deliver value to patients, payors, acquirers, and investors.

Sign up for free to view info

Email Format Employee directory